Latest News and Press Releases
Want to stay updated on the latest news?
-
Sol-Gel Announces the Signing of Six Exclusive License Agreements to Commercialize TWYNEO® and EPSOLAY® in Europe and South Africa
-
Sol-Gel Technologies Announces Management Realignment
-
Sol-Gel Announces Receipt of Nasdaq Minimum Price Notice
-
Sol-Gel and Beimei Pharma annouce an Asset Purcase Agreement to commercialize TWYNEO® in the Mainland of China, Hong Kong, Macau, Taiwan and Israel